Sponsors & Exhibitors

Platinum Partner

Illumina is a global leader in genomics – an industry at the intersection of biology and technology. Our mission is to improve human health by unlocking the power of the genome. Through innovation and collaboration, we are enabling genomic breakthroughs and helping simplify the patient diagnostic odyssey.

We dream big. We strive to make solutions increasingly simple, more accessible and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination.

https://sapac.illumina.com/areas-of-interest/genetic-disease.html

Conference App Partner

Alexion is focused on providing innovative treatments to patients with life-threatening rare diseases. We work in partnership with healthcare providers, patient advocacy organisations and governments to best serve patients. By expanding the knowledge and awareness of rare diseases, we help the medical community improve the process for diagnosis and treatment. Our goal is to bring hope to patients and families by delivering life-changing therapies.

Our Medicines:

In Australia, STRENSIQ® (asfotase alfa, rch) is registered for the treatment of paediatric-onset hypophosphatasia (HPP). STRENSIQ is funded under the Life Saving Drugs Program for perinatal or infantile-onset HPP. Product Information for STRENSIQ can be accessed here and Consumer Medicine Information here.

Alexion is committed to seeking government reimbursement for KANUMA® (sebelipase alfa, rce) registered in Australia for the treatment of lysosomal acid lipase deficiency (LAL-D), a severe, ultra-rare metabolic disease. Product information for KANUMA can be accessed here and Consumer Medicine Information here.

Scientific Program Partners

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. We are also selectively active in the areas of autoimmunity, neuroscience and infection. We build our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines.

https://www.astrazeneca.com.au/

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialisation of clinically differentiated medicines that provide benefits to patient with rare disorders. PTC’s ability to globally commercialise products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on Twitter at @PTCBio and on LinkedIn.

Thermo Fisher Scientific is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer. Our comprehensive range includes high-end analytical and process instrumentation, laboratory equipment, a complete range of consumables, chemicals and reagents as well as the service and support to optimise your results. We’ve combined sales and service teams to make it easier for customers to connect with all our capabilities and leading global brands. Our local team of more than 1000 employees are working together across Australia and New Zealand to provide unparalleled industry, product and application expertise. From research to academia; diagnostics, medical and healthcare; biotechnology and pharmaceutical; food, diary and beverage; manufacturing and utilities; heavy industry, minerals, mining & petrochemical; environmental gas, water and assessment technologies.

Barista Partners

BioMarin brings first- or best-in-class therapies for patients living with rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and life-threatening conditions where we can significantly improve upon the current standard of care. Our culture revolves around the ethos that no disease should go untreated, and our people are driven to discover, develop, and commercialise medicines that give patients, their families, and their caregivers hope where there was little or none. Discover now: www.biomarin.com.au

At Invitae, we believe that good health is possible - and that genetic information has the ability to transform the way medicine is practiced, making what once seemed impossible possible, as we empower people to make decisions about their health through the power of genetics.

Industry Session Partners